Bio-Path Holdings, Inc.
BPTH Healthcare Biotechnology
In the quarter to March 2026, EPS fell 101.2% and free cash flow grew 98.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
Follow BPTH
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
1.17 | 1.05 | 10.38 | 23.77 | 13.76 | 20.43 | 1.00 | 5.97 | 9.38 |
Other current assets |
1.53 | 1.36 | 1.64 | 1.84 | 0.93 | 0.79 | 0.80 | 0.35 | 0.90 |
Total current assets |
3.78 | 3.04 | 15.62 | 26.14 | 15.96 | 21.99 | 2.14 | 7.44 | 10.65 |
Property, Plant, Equpment (Net) |
0.02 | 0.08 | 0.16 | 0.23 | 0.23 | 0.30 | 0.41 | 0.65 | 0.61 |
Goodwill and Intangible Assets (Total) |
— | — | — | — | — | — | — | 0.77 | 0.93 |
Total non-current assets |
0.11 | 0.18 | 0.36 | 0.43 | 0.52 | 0.67 | 0.41 | 1.42 | 1.54 |
Total Assets |
3.88 | 3.22 | 15.97 | 26.57 | 16.48 | 22.66 | 2.55 | 8.86 | 12.20 |
Accounts Payable |
1.27 | 0.46 | 0.67 | 0.11 | 0.10 | 0.49 | 0.59 | 0.05 | 0.07 |
Accrued Expenses |
1.94 | 1.35 | 0.91 | 0.77 | 0.98 | 0.67 | 0.74 | 0.74 | 0.97 |
Current Revenue (Deferred) |
— | — | — | — | — | — | — | — | 0.01 |
Total current liabilities |
3.30 | 1.91 | 1.68 | 0.96 | 1.17 | 1.24 | 1.33 | 0.79 | 1.05 |
Non-current Liabilities (Other) |
0.43 | 0.86 | — | — | — | — | — | — | 2.91 |
Total non-current liabilities |
0.43 | 0.87 | 0.11 | 0.15 | 0.24 | 0.33 | — | — | 2.91 |
Total liabilities |
3.73 | 2.78 | 1.80 | 1.11 | 1.41 | 1.57 | 1.33 | 0.79 | 3.96 |
Additional Paid In Capital |
117.65 | 108.05 | 105.70 | 103.11 | 82.29 | 77.42 | 48.96 | 47.22 | 40.36 |
Common Stock (Net) |
0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
Retained Earnings |
(117.50) | (107.61) | (91.53) | (77.66) | (67.22) | (56.34) | (47.74) | (39.16) | (32.13) |
Common Equity (Total) |
0.15 | 0.44 | 14.17 | 25.46 | 15.07 | 21.09 | 1.22 | 8.07 | 8.24 |
Shareholders Equity (Total) |
0.15 | 0.44 | 14.17 | 25.46 | 15.07 | 21.09 | 1.22 | 8.07 | 8.24 |
Shareholders Equity and Liabilities (Total) |
3.88 | 3.22 | 15.97 | 26.57 | 16.48 | 22.66 | 2.55 | 8.86 | 12.20 |
Shares (Common) |
5.77 | 0.62 | 0.40 | 0.36 | 0.23 | 0.18 | 0.03 | 0.03 | 0.02 |
Shareholders Equity (Tangible) |
0.15 | 0.44 | 14.17 | 25.46 | 15.07 | 21.09 | 1.22 | 7.30 | 7.31 |
Net Debt |
(1.17) | (1.05) | (10.38) | (23.77) | (13.75) | (20.43) | (1.00) | (5.96) | (9.37) |
Total Debt |
— | — | 0.22 | 0.24 | 0.33 | 0.42 | — | — | — |